Thiols, Malonaldehyde and total antioxidant status in the Turkish patients with type 2 diabetes mellitus

Tohoku Journal of Experimental Medicine

Volumn 201, Issue 3, 2003, Pages 147-155

  Duman, Belgin Süsleyici ^c   Öztürk, Melek ^a   Yilmazer, Selma ^a   Hatemi, Hüsrev ^a,b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Turkish Diabetes Hospital   (Turkey)

^c KADIR HAS UNIVERSITY   (Turkey)

Author keywords

Lipid peroxidation; NIDDM; Oxidative stress; Sex

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CYSTEINE; CYSTEINYLGLYCINE; GAMMA GLUTAMYLCYSTEINE; GLUCOSE; GLUTATHIONE; HOMOCYSTEINE; MALONALDEHYDE; THIOL; TRANSFERASE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RISK FACTOR; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIOXIDANTS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CATALYSIS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; DIABETES MELLITUS, TYPE 2; DIPEPTIDES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; HOMOCYSTEINE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; SEX FACTORS; SMOKING; SULFHYDRYL COMPOUNDS; TURKEY;

EID: 0345530940     PISSN: 00408727     EISSN: None     Source Type: Journal    
DOI: 10.1620/tjem.201.147     Document Type: Article

References (40)

1. Angelico, F., Del Ben, M., Giampaoli, S., Menotti, A., Ricci, G., Savocchi, P., Spitoni, M., Volpe, R. & Urbinati, G.C. (1990) High prevalence of obesity in rural community of central Italy: The "Di.S.Co." project. In: World Data Book of Obesity, "6th International Congress on Obesity", edited by S. Baba & P. Zimmet, Excerpta Medica, Amsterdam.
2. Araki, A., Sako, Y., Fukushima, Y., Matsumoto, M., Asada, T. & Kita, T. (1989) Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis, 79, 139-146.
3. Assmann, G., Carmena, R., Cullen, P., Fruchart, J.C., Jossa, F., Lewis, B., Mancini, M. & Paoletti, R. (1999) Coronary heart disease, reducing the risk: a worldwide view. International Task Force for the Prevention of Coronary Heart Disease. Circulation, 100, 1930-1938.
4. Block, G., Dietrich, M., Norkus, E.P., Morrow, J.D., Hudes, M., Caan, B. & Packer, L. (2002) Factors associated with oxidative stress in human populations. Am. J. Epidemiol., 156, 274-285.
5. Boemi, M., James, R.W., Romagnoli, E., Gerber, P., Pometta, D. & Fumelli, P. (1993) Gender differences in a Type 2 (NIDDM) diabetic population. Diabetologia, 36, 29-233.
6. Boushey, C.J., Beresford, S.A., Omenn, G.S. & Motulsky, A.G. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA, 274, 1049-1057.
7. Cao, G. & Prior, R.L. (1998) Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin. Chem., 44, 1309-1315.
8. Carbonneau, M.A., Peuchant, E., Sess, D., Canioni, P. & Clerc, M. (1991) Free and bound malondialdehyde measured as thiobarbituric acid adduct by HPLC in serum and plasma. Clin. Chem., 37, 1423-1429.
9. Ceriello, A., Bortolotti, N., Falleti, E., Taboga, C., Tonutti, L., Crescentini, A., Motz, E., Lizzio, S., Russo, A. & Bartoli, E. (1997) Total radical-trapping antioxidant parameter in NIDDM patients. Diabetes Care, 20, 194-197.
10. Chico, A., Perez, A., Cordoba, A., Arcelus, R., Carreras, G., de Leiva, A., Gonzalez-Sastre, F. & Blanco-Vaca, F. (1998) Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease. Diabetologia, 41, 684-693.
11. Das, S., Reynolds, T., Patnaik, A., Rais, N., Fink, L.M. & Fonseca, V.A. (1999) Plasma homocysteine concentrations in Type II diabetic patients in India: relationship to body weight. J. Diabetes Complicat., 13, 200-203.
12. De Zwart, L.L., Meerman, J.H., Commandeur, J.N. & Vermeulen, N.P. (1999) Biomarkers of free radical damage applications in experimental animals and in humans. Free. Radic. Biol. Med., 26, 202-226.
13. Diaz, J., Serrano, E., Acosta, F. & Carbonell, L.F. (1998) Reference intervals for four biochemistry analytes in plasma for evaluating oxidative stress and lipid peroxidation in human plasma. Clin. Chem., 44, 2215-2217.
14. Drozdz, R., Parmentier, C., Hachad, H., Leroy, P., Siest, G. & Wellman, M. (1998) γ-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic. Biol. Med., 25, 786-792.
15. Enoiu, M., Aberkane, H., Salazar, J.F., Leroy, P., Groffen, J., Siest, G. & Wellman, M. (2000) Evidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzyme. Free Radic. Biol. Med., 29, 825-833.
16. Garewal, H.S. (1997) Antioxidants and Disease Prevention. CRC Press Ltd., New York.
17. Ghiselli, A., Laurenti, O., De Mattia, G., Maiani, G. & Ferro-Luzzi, A. (1992) Salicylate hydroxylation as an early marker of oxidative stress in diabetic patients. Free Radic. Biol. Med., 13, 621-626.
18. Graham, I.M., Daly, L.E., Refsum, H.M., Robinson, K., Brattstrom, L.E., Ueland, P.M., Palma-Reis, R.J., Boers, G.H., Sheahan, R.G., Israelsson, B., Uiterwaal, C.S., Meleady, R., McMaster, D., Verhoef, P., Witteman, J., Rubba, P., Bellet, H., Wautrecht, J.C., de Valk, H. W., Sales Luis, A.C., Parrot-Rouland, F.M., Tan, K.S., Higgins, I., Garcon, D. & Andria, G. (1997) Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA, 22, 1775-1781.
19. Hoogeveen, E.K., Kostense, P.J., Beks, P.J., Mackaay, A.J., Jakobs, C., Bouter, L.M., Heine, R.J. & Stehouwer, C.D. (1998) Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population based study. Arterioscler. Thromb. Vasc. Biol., 18, 133-138.
20. Ide, T., Tsutsui, H., Ohashi, N., Hayashidani, S., Suematsu, N., Tsuchihashi, M., Tamai, H. & Takeshita, A. (2002) Greater oxidative stress in healthy young men compared with premenopausal women. Arterioscler. Thromb. Vasc. Biol., 22, 438-442.
21. Jacob, R.A. & Burri, H.S. (1996) Oxidative damage and defense. Am. J. Clin. Nutr., 63, 985S-990S.
22. Langley, S.C., Brown, R.K. & Kelly, F.J. (1993) Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr. Res., 33, 247-250.
23. Leinonen, J., Rantalaiho, V., Lehtimaki, T., Wirta, O., Pasternack, A. & Alho, H. (1998) The association between the total antioxidant potential of plasma and the presence of coronary heart disease and renal dysfunction in patients with NIDDM. Free Radic. Res., 29, 273-281.
24. Mansoor, M.A., Bergmark, C., Svardal, A.M., Lønning, P.E. & Ueland, P.M. (1995) Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Homocysteine and peripheral vascular disease. Arterioscler. Thromb. Vasc. Biol., 15, 232-240.
25. Maxwell, S.R., Thomason, H., Sandler, D., LeGuen, C., Baxter, M.A., Thorpe, G.H., Jones, A.F. & Barnett, A.H. (1997) Poor glycaemic control is associated with reduced serum free radical scavenging (antioxidant) activity in non-insulin-dependent diabetes mellitus. Ann. Clin. Biochem., 34, 638-644.
26. Meister, A. & Tate, S.S. (1976) Glutathione and related g-glutamyl compounds: biosynthesis and utilization. Annu. Rev. Biochem., 45, 609-616.
27. Miller, N.J., Rice-Evans, C., Davies, M.J., Gopinathan, V. & Milner, A. (1993) A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin. Sci., 84, 407-412.
28. Munshi, M., Stone, A., Fink, L. & Fonseca, V. (1996) Hyperhomocysteinemia following a methionine load in non-insulin dependent diabetes and microvascular disease. Metabolism, 45, 133-135.
29. Nourooz-Zadeh, J., Rahimi, A., Tajaddini-Sarmadi, J., Tritschler, H., Rosen, P., Halliwell, B. & Betteridge, D.J. (1997) Relationships between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia, 40, 647-653.
30. Perry, I.J., Wannamethee, S.G. & Shaper, A.G. (1998) Prospective study of serum gamma-glutamyltransferase and risk of NIDDM. Diabetes Care, 21, 732-737.
31. Pompella, A. (1997) Biochemistry and histochemistry of oxidant stress and lipid peroxidation. Int. J. Vitam. Nutr. Res., 67, 289-297.
32. Salazar, J.F., Schorr, H., Herrmann, W., Herbeth, B., Siest, G. & Leroy, P. (1999) Measurement of thiols in human plasma using liquid chromatography with precolumn derivatization and fluorescence detection. J. Chromatogr. Sci., 37, 469-476.
33. Stamler, J.S., Osborne, J.A., Jaraki, O., Rabbani, L.E., Mullins, M., Singel, D. & Loscalzo, J. (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J. Clin. Invest., 91, 308-318.
34. Stamler, J.S. & Slivka, A. (1996) Biological chemistry of thiols in the vasculature and in vascular-related disease. Nutr. Rev., 54, 1-30.
35. Sundaram, R.K., Bhaskar, A., Vijayalingam, S., Viswanathan, M., Mohan, R. & Shanmugasundaram, K.R. (1996) Antioxidant status an lipid peroxidation in type II diabetes mellitus with and without complications. Clin. Sci., 90, 255-260.
36. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2000) Diabetes Care, 23, S4-S19.
37. Ueland, P.M., Refsum, H. & Brattsrom, L. (1992) Plasma homocysteine and cardiovascular disease. In: Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, edited by R.B. Jr., Francis, Marcel Dekker Inc., New York, pp. 183-236.
38. Verhoef, P., Stampfer, M.J., Buring, J.E., Gaziano, J.M., Allen, R.H., Stabler, S.P., Reynolds, R.D., Kok, F.J., Hennekens, C.H. & Willett, W.C. (1996) Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12 and folate. Am. J. Epidemiol., 143, 845-859.
39. Vijayalingam, S., Parthiban, A., Shanmugasundaram, K.R. & Mohan, V. (1996) Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus. Diabetic Med., 13, 715-719.
40. Young, I.S. & Trimble, E.R. (1991) Measurement of malondialdehyde in plasma by high performance liquid chromatography with fluorimetric detection. Ann. Clin. Biochem., 28, 504-508.